Epidemiology, Technology, and Professional Perspectives on Diabetes in the United Arab Emirate: A Focused Review

Abstract

Introduction The United Arab Emirates (UAE), among the rest of the Arab Gulf countries, exhibits a high prevalence of diabetes, primarily type 2 diabetes (T2D).

Methods We aimed to provide an overview of the epidemiology, complications, and quality of care, including the use of technology in diabetes care. Also, we wished to explore the challenges of diabetes management and future directions in clinical practice and research. This is a focused review of the literature of selected relevant themes to serve the above objectives of the work.

Results Several epidemiological studies have documented the increased prevalence of diabetes in the native population and expatriates. The vast majority focused on T2D. The prevalence of diabetes in the UAE is estimated at 12.3% for the 20 to 79 age group. Although the high prevalence was recognized and acknowledged as a national priority, several challenges exist in standardizing care across the population. There are gaps in research about the nationwide prevalence of all forms of diabetes. Some research studies have evaluated the role of technology in diabetes care, genetic predilection to complications, and particular aspects such as diabetes during pregnancy, neonatal diabetes, monogenic diabetes, and cardiovascular risk in diabetes. UAE recently became a focal point for health-related Ramadan fasting research, including diabetes.

Conclusion Diabetes in the UAE considerably burdens the health care system. A concerted effort is needed to adopt more uniformity of diabetes care and research nationwide. This should address the use of unified methods to document the nationwide burden, explore possible differences in various epidemiological phenomena, access to health care, and impact on outcomes, and evaluation of the cost-effectiveness of different models of care.

Keywords

complications - diabetes - diabetes care - epidemiology - management - professionalism - United Arab Emirates

Author Contributions

All authors contributed equally to this article's drafting, revision, and finalization. K.M.D. proposed the article and assigned sections to different authors. All authors prepared their assigned sections of the manuscript and revised and approved it.

Compliance with Ethical Principles

No ethical approval is required.

Publikationsverlauf

Artikel online veröffentlicht:
11. April 2024

• References

• 1 International Diabetes Federation. IDF Diabetes Atlas, 10th edition. 2021 . Accessed July 27, 2022 at: https://www.diabetes-atlas.org/en/resources
• 2 Khalil AB, Beshyah SA, Abdella N. et al. Diabesity in the Arabian Gulf: challenges and opportunities. Oman Med J 2018; 33 (04) 273-282
• 3 Malik M, Bakir A, Saab BA, King H. Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national survey. Diabetes Res Clin Pract 2005; 69 (02) 188-195
• 4 Saadi H, Carruthers SG, Nagelkerke N. et al. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract 2007; 78 (03) 369-377
• 5 Hajat C, Harrison O, Al Siksek Z. Weqaya: a population-wide cardiovascular screening program in Abu Dhabi, United Arab Emirates. Am J Public Health 2012; 102 (05) 909-914
• 6 Sulaiman N, Mahmoud I, Hussein A. et al. Diabetes risk score in the United Arab Emirates: a screening tool for the early detection of type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2018; 6 (01) e000489
• 7 Sulaiman N, Albadawi S, Abusnana S. et al. High prevalence of diabetes among migrants in the United Arab Emirates using a cross-sectional survey. Sci Rep 2018; 8 (01) 6862
• 8 Hamoudi R, Saheb Sharif-Askari N, Saheb Sharif-Askari F. et al. Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates. Sci Rep 2019; 9 (01) 17437
• 9 Alawadi F, Hassanein M, Sulaiman E. et al. The prevalence of diabetes and prediabetes among the population: finding from Dubai household survey 2014 and 2017. Dubai Diabetes Endocrinol J 2020; 26 (02) 78-84
• 10 Al Awadi F, Hassanein M, Hussain HY. et al. Prevalence of diabetes and associated health risk factors among adults in Dubai, United Arab Emirates: results from Dubai Household Survey 2019. Dubai Diabetes Endocrinol J 2020; 26: 164-173
• 11 Sreedharan J, Muttappallymyalil J, Al Sharbatti S. et al. Incidence of type 2 diabetes mellitus among Emirati residents in Ajman, United Arab Emirates. Korean J Fam Med 2015; 36 (05) 253-257
• 12 Maddaloni E, Lessan N, Al Tikriti A, Buzzetti R, Pozzilli P, Barakat MT. Latent autoimmune diabetes in adults in the United Arab Emirates: clinical features and factors related to insulin-requirement. PLoS One 2015; 10 (08) e0131837
• 13 Deeb A, Habeb A, Kaplan W. et al. Genetic characteristics, clinical spectrum, and incidence of neonatal diabetes in the Emirate of Abu Dhabi, United Arab Emirates. Am J Med Genet A 2016; 170 (03) 602-609
• 14 Mohamad MN, Ismail LC, Stojanovska L. et al. The prevalence of diabetes amongst young Emirati female adults in the United Arab Emirates: a cross-sectional study. PLoS One 2021; 16 (06) e0252884
• 15 Meo SA, Sheikh SA, Sattar K. et al. Prevalence of type 2 diabetes mellitus among men in the Middle East: a retrospective study. Am J Men Health 2019; 13 (03) 1557988319848577
• 16 Barakat C, Yousufzai SJ, Booth A, Benova L. Prevalence of and risk factors for diabetes mellitus in the school-attending adolescent population of the United Arab Emirates: a large cross-sectional study. BMJ Open 2021; 11 (09) e046956
• 17 Beshyah SA, Blouza-Chabchoub S. Diabetes and pregnancy. In: Lakhdar AA. & Gill GV. eds. Diabetes in The Arab World. Cambridge: FSG Communications Ltd.; 2005. :249–67.
• 18 Al-Rifai RH, Majeed M, Qambar MA, Ibrahim A, AlYammahi KM, Aziz F. Type 2 diabetes and pre-diabetes mellitus: a systematic review and meta-analysis of prevalence studies in women of childbearing age in the Middle East and North Africa, 2000-2018. Syst Rev 2019; 8 (01) 268
• 19 Abdulrazzaq YM, Bener A, Dawodu A. et al. Obstetric risk factors affecting incidence of low birth weight in live-born infants. Biol Neonate 1995; 67 (03) 160-166
• 20 Hughes PF, Morrison J. Pregnancy outcome data in a United Arab Emirates population: what can they tell us?. Asia Oceania J Obstet Gynaecol 1994; 20 (02) 183-190
• 21 Hughes PF, Agarwal M, Newman P, Morrison J. Screening for gestational diabetes in a multi-ethnic population. Diabetes Res Clin Pract 1995; 28 (01) 73-78
• 22 Agarwal MM, Hughes PF, Ezimokhai M. Screening for gestational diabetes in a high-risk population using fasting plasma glucose. Int J Gynaecol Obstet 2000; 68 (02) 147-148
• 23 Bashir MM, Ahmed LA, Elbarazi I. et al Incidence of gestational diabetes mellitus in the United Arab Emirates; comparison of six diagnostic criteria: The Mutaba'ah Study. Front Endocrinol (Lausanne) 2022; 12 (13) 1069477
• 24 Khair H, Bataineh MF, Zaręba K. et al. Pregnant women's perception and knowledge of the impact of obesity on prenatal outcomes—a cross-sectional study. Nutrients 2023; 15 (11) 2420
• 25 Sadiya A, Jakapure V, Shaar G, Adnan R, Tesfa Y. Lifestyle intervention in early pregnancy can prevent gestational diabetes in high-risk pregnant women in the UAE: a randomized controlled trial. BMC Pregnancy Childbirth 2022; 22 (01) 668
• 26 Juber NF, Abdulle A, AlJunaibi A. et al. Maternal early-life risk factors and later gestational diabetes mellitus: a cross-sectional analysis of the UAE Healthy Future Study (UAEHFS). Int J Environ Res Public Health 2022; 19 (16) 10339
• 27 Hassanein M, Abuelkheir S, Alsayyah F. et al. Evaluation of optimum diabetes care on glycemic control of patients with gestational diabetes during Ramadan fasting. Diabetes Res Clin Pract 2021; 173: 108669
• 28 Afandi B, Hassanein M, Roubi S, Nagelkerke N. The value of continuous glucose monitoring and self-monitoring of blood glucose in patients with gestational diabetes mellitus during Ramadan fasting. Diabetes Res Clin Pract 2019; 151: 260-264
• 29 Alkaabi J, Almazrouei R, Zoubeidi T. et al. Burden, associated risk factors and adverse outcomes of gestational diabetes mellitus in twin pregnancies in Al Ain, UAE. BMC Pregnancy Childbirth 2020; 20 (01) 612
• 30 Buse JB, Wexler DJ, Tsapas A. et al. 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020; 43 (02) 487-493
• 31 Cosentino F, Grant PJ, Aboyans V. et al; ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020; 41 (02) 255-323
• 32 UAE National Diabetes Committee. National diabetes guidelines: United Arab Emirates 2009. Abu Dhabi, UAE:: The UAE National Diabetes Committee.; 2009
• 33 Alawadi F, Abusnana S, Afandi B. et al. Emirates diabetes society consensus guidelines for the management of type 2 diabetes mellitus—2020. Dubai Diabetes Endocrinol J 2020 (e-pub ahead of print).
• 34 American Diabetes Association Professional Practice Committee. 4 Comprehensive medical evaluation and assessment for comorbidities: standards of medical care in diabetes—2022. Diabetes Care 2022; 45 (Suppl. 01) S46-S59
• 35 American Diabetes Association Professional Practice Committee. 6. Glycemic targets: standards of medical care in diabetes—2022. Diabetes Care 2022; 45 (Suppl. 01) S83-S96
• 36 American Diabetes Association Professional Practice Committee. 5 Facilitating behavior change and well-being to improve health outcomes: standards of medical care in diabetes—2022. Diabetes Care 2022; 45 (Suppl. 01) S60-S82
• 37 Al-Farsi MA, Lee CY. Nutritional and functional properties of dates: a review. Crit Rev Food Sci Nutr 2008; 48 (10) 877-887
• 38 Alkaabi JM, Al-Dabbagh B, Ahmad S, Saadi HF, Gariballa S, Ghazali MA. Glycemic indices of five varieties of dates in healthy and diabetic subjects. Nutr J 2011; 10: 59
• 39 Al-Kaabi J, Al-Maskari F, Saadi H, Afandi B, Parkar H, Nagelkerke N. Physical activity and reported barriers to activity among type 2 diabetic patients in the United Arab Emirates. Rev Diabet Stud 2009; 6 (04) 271-278
• 40 American Diabetes Association Professional Practice Committee. 9 Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2022. Diabetes Care 2022; 45 (Suppl. 01) S125-S143
• 41 American Diabetes Association Professional Practice Committee. 10 Cardiovascular disease and risk management: standards of medical care in diabetes—2022. Diabetes Care 2022; 45 (Suppl. 01) S144-S174
• 42 Gehani AA, Al-Hinai AT, Zubaid M. et al; INTERHEART Investigators in Middle East. Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study. Eur J Prev Cardiol 2014; 21 (04) 400-410
• 43 Alzaabi A, Al-Kaabi J, Al-Maskari F. et al. Prevalence of diabetes and cardio-metabolic risk factors in young men in the United Arab Emirates: a cross-sectional national survey. Endocrinol Diab Metabol 2019; 2 (Suppl. 04) e00081
• 44 American Diabetes Association Professional Practice Committee. . 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022. Diabetes Care . 2022(01); 45 (Suppl 1): S97-S112
• 45 WHO. 2011 mHealth: new horizons for health through mobile technologies. Based on the findings of the second global survey on eHealth. Global Observatory for eHealth Series – Volume 3. WHO, Geneva. Accessed September 17, 2018 at: www.who.Int/goe/publications/goe_mhealth_web.pdf.
• 46 Elenko E, Speier A, Zohar D. A regulatory framework emerges for digital medicine. Nat Biotechnol 2015; 33 (07) 697-702
• 47 AADE. AADE7 self-care behaviors. Diabetes Educ 2008; 34 (03) 445-449
• 48 Dungan K, Verma N, Reddy N. Monitoring Technologies–Continuous Glucose Monitoring,. Mobile Technology, Biomarkers of Glycemic Control, Endotext, South Dartmouth, MA 2015
• 49 Mcgarraugh G, Bragg R, Weinstein R. FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart algorithm, a 1-hour warm-up time. J Diabetes Sci Technol 2011; 5 (01) 99-106
• 50 Welsh JB, Gao P, Derdzinski M. et al. Accuracy, utilization, and effectiveness comparisons of different continuous glucose monitoring systems. Diabetes Technol Ther 2019; 21 (03) 128-132
• 51 Wright LA, Hirsch IB. Metrics beyond haemoglobin A1C in diabetes management: time in range, hypoglycemia, and other parameters. Diabetes Technol Ther 2017; 19 (S2): S16-S26
• 52 Danne T, Nimri R, Battelino T. et al. International consensus on the use of continuous glucose monitoring. Diabetes Care 2017; 40 (12) 1631-1640
• 53 Alawadi F, Rashid F, Bashier A. et al. The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care. Diabetes Res Clin Pract 2019; 151: 305-312
• 54 Hassanein M, Rashid F, Elsayed M. et al. Assessment of risk of fasting during Ramadan under optimal diabetes care, in high-risk patients with diabetes and coronary heart disease through the use of FreeStyle Libre Flash Continuous Glucose Monitor (FSL-CGMS). Diabetes Res Clin Pract 2019; 150: 308-314
• 55 Afandi BO, Kaplan W, Majd L. et al. Rate, Timing, and Severity of hypoglycemia in adolescents with Type 1 diabetes during ramadan fasting: A study with FreeStyle Libre Flash Glucose Monitoring System. Ibnosina J Med Biomed Sci 2018; 10: 9-11
• 56 Ehtisham S, Adhami S. Accuracy of Glucose Sensor Estimate of HbA1c in Children with Type 1 Diabetes. ESPE Abstracts 2019; 92: RFC7.1
• 57 Farooqi MH, Abdelmannan DK, Al Buflasa MM. et al. The impact of telemonitoring on improving glycemic and metabolic control in previously lost-to-follow-up patients with type 2 diabetes mellitus: a single-center interventional study in the United Arab Emirates. Int J Clin Pract 2022; 2022: 6286574
• 58 Ashraf T, Helal R, Majeed M. et al. An analysis of flash glucose monitoring (FGM) data on insulin-treated patients with diabetes: effects of COVID-19 lockdown. Endocrine Abstracts 2021; (e-pub ahead of print). doi.
• 59 Al Kaabi JM, Alsayed N, Al-Ozairi E. Abstracts of the Free Communications of the Fifth Clinical Congress of the Gulf Chapter of the American Association of Clinical Endocrinologists. J Diab Endocr Pract 2018; 1 (01) 35-54
• 60 AlSayed N, Saleh Y, Aljuhani N. Gulf association of endocrinology and diabetes is born: history in the making. J Diab Endocrine Pract 2021; 4 (01) 41-42
• 61 Elbarbary N, Deeb A, Habeb A, Beshyah SA. Management of diabetes during Ramadan fasting in children and adolescents: a survey of physicians' perceptions and practices in the Arab Society for Paediatric Endocrinology and Diabetes (ASPED) countries. Diabetes Res Clin Pract 2019; 150: 274-281
• 62 Deeb A, Elbarbary N, Smart CE. et al. ISPAD Clinical Practice Consensus Guidelines: fasting during Ramadan by young people with diabetes. Pediatr Diabetes 2020; 21 (01) 5-17
• 63 Beshyah SA. IDF-DAR practical guidelines for management of diabetes during ramadan. Ibnosina J Med Biomed Sci 2016; 8 (03) 58-60
• 64 Beshyah SA, Hafidh K. Highlights of the Ninth Diabetes and Ramadan International Alliance conference (mena-zone virtual), January 21–22, 2021 Ibnosina. J Med Biomed Sci 2021; 13 (02) 95-100
• 65 Kenz S, Abusahmin H, Elmalti A. et al. The 8th Diabetes and Ramadan International Alliance Conference: January 23–24, 2020, Dubai, United Arab Emirates. Ibnosina J Med Biomed Sci 2020; 12: 62-67
• 66 Beshyah SA, Rashid F, Abdelghader LI. Highlights of the 11th Emirates Diabetes & Endocrine Virtual Congress (EDEC21), 4–6 March 2021. Dubai Diabetes Endocrinol J 2022; 28: 1-19
• 67 Regmi D, Al-Shamsi S, Govender RD, Al Kaabi J. Incidence and risk factors of type 2 diabetes mellitus in an overweight and obese population: a long-term retrospective cohort study from a Gulf state. BMJ Open 2020; 10 (07) e035813
• 68 Mahmoud I, Sulaiman N. Prevalence of metabolic syndrome and associated risk factors in the United Arab Emirates: a cross-sectional population-based study. Front Public Health 2022; 9: 811006
• 69 Al-Maskari F, El-Sadig M, Obineche E. Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates. BMC Nephrol 2008; 9: 1
• 70 Al-Shamsi S, Govender RD, Soteriades ES. Mortality and potential years of life lost attributable to non-optimal glycaemic control in men and women with diabetes in the United Arab Emirates: a population-based retrospective cohort study. BMJ Open 2019; 9 (09) e032654